KANNAN RAJ 4
4 · AERIE PHARMACEUTICALS INC · Filed Dec 22, 2021
Insider Transaction Report
Form 4
KANNAN RAJ
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2021-12-20+215,783→ 215,783 total - Award
Stock Option (right to buy)
2021-12-20+387,169→ 387,169 totalExercise: $8.11Exp: 2031-12-20→ Common Stock (387,169 underlying)
Footnotes (2)
- [F1]These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of December 20, 2021.
- [F2]This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on December 20, 2022 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of December 20, 2022.